Phase 2 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 to 75 years old (both ages included), of any sex.
- People with breast cancer that cannot be surgically removed, or that has come back, or that has spread to other parts of the body.
- People whose tumour tissue has tested positive for HER2 (a specific protein), based on specific lab test results (IHC3+ or FISH+).
- People who have already received a treatment called T-DXd at the advanced stage of their breast cancer.
- People whose bone marrow, liver, kidneys, and blood clotting are all functioning at an adequate level.
- People who are willing to sign a consent form, attend follow-up visits, and follow the trial requirements.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose cancer has spread to the lining of the brain or spine, or who have cancer spread throughout the brain, or have brain metastases that are currently active.
- People who have lung disease affecting the tissue between the air sacs (interstitial lung disease) that requires steroid treatment, or who have a history of lung damage caused by medication or radiation, or any signs of currently active interstitial lung disease.
- People who have an eye condition requiring medical treatment, such as inflammation of the cornea, other corneal diseases, or an active eye infection.
- People who have heart failure or insufficient heart function.
- People who have received any whole-body anti-cancer treatment within 28 days (or within at least 5 half-lives of that treatment) before starting the trial, except for hormone-based treatments, which must have been stopped at least 7 days before.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8664175590
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Objective remission rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.